Abstract PD01-01: Cetuximab + Cisplatin in Estrogen Receptor-Negative, Progesterone Receptor-Negative, HER2-Negative (Triple-Negative) Metastatic Breast Cancer: Results of the Randomized Phase II BALI-1 Trial

2010 ◽  
Author(s):  
J Baselga ◽  
S Stemmer ◽  
A Pego ◽  
A Chan ◽  
J-C Goeminne ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Metastatic Breast Cancer ◽  
Progesterone Receptor ◽  
Phase Ii ◽  
Triple Negative ◽  
Metastatic Breast ◽  
Randomized Phase Ii ◽  
Estrogen Receptor Negative

scholarly journals Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer

2013 ◽  
Vol 19 (19) ◽  
pp. 5505-5512 ◽  
Author(s):  
Ayca Gucalp ◽  
Sara Tolaney ◽  
Steven J. Isakoff ◽  
James N. Ingle ◽  
Minetta C. Liu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Metastatic Breast Cancer ◽  
Androgen Receptor ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Estrogen Receptor Negative
Sign in / Sign up

Export Citation Format

Share Document